Abstract
GEN EdgeVol. 5, No. 1 TopicsBeacon of Light: Retinal Gene Therapy Developer Launches with $120MPipeline includes AGTC's XLRP program, two preclinical candidatesAlex PhilippidisAlex PhilippidisSearch for more papers by this authorPublished Online:12 Jun 2023https://doi.org/10.1089/genedge.5.1.84AboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View articleFiguresReferencesRelatedDetails Volume 5Issue 1Jan 2023 Information© 2023 by GEN PublishingTo cite this article:Alex Philippidis.Beacon of Light: Retinal Gene Therapy Developer Launches with $120M.GEN Edge.Jan 2023.429-435.http://doi.org/10.1089/genedge.5.1.84Published in Volume: 5 Issue 1: June 12, 2023PDF download
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
